Scinai Immunotherapeutics share price logo

Scinai Immunotherapeutics

NASDAQ: SCNI

$0.47

-0.05

(-9.05%)

as on

Scinai Immunotherapeutics Stock Performance

as on October 31, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.47
    $0.52
    downward going graph

    0.34%

    Downside

    10.26%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.50
    $15.50
    downward going graph

    -6.66%

    Downside

    3186.47%

    Upside

    downward going graph

Scinai Immunotherapeutics share price movements today

Previous Close
$0.52
Open
$0.52
Volume
294.2K
Market Cap
$724.0K
Day's Low - High
$0.47 - $0.52
52 Week Low - High
$0.50 - $15.50

Scinai Immunotherapeutics Historical Returns

1 Month Return
-63.49 %
3 Month Return
-81.21 %
1 Year Return
-96.45 %
3 Year Return
-99.19 %
5 Year Return
0 %

Scinai Immunotherapeutics Stock Fundamentals & Key Indicators

Check Scinai Immunotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$724.0K

EPS (TTM)

-62161.6

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.87%

PE Ratio (TTM)

0

Industry PE ratio

-2.98

PEG Ratio

0.00

EBITDA

-6.7M

Revenue (TTM)

1.5M

Profit Margin

-252.45%

Return On Equity TTM

-26.63%

Scinai Immunotherapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Scinai Immunotherapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$724.0KNANA-252.45%0.00%
Neutral$85.5B-35.47%-26.84-12.57%0.00%
StrongBuy$134.2B192.00%30.5886.04%0.00%
Buy$83.7B27.94%19.4284.86%0.45%

Stock Returns calculator for Scinai Immunotherapeutics Stock including INR - Dollar returns

The Scinai Immunotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Scinai Immunotherapeutics investment value today

Current value as on today

₹3,460

Returns

-₹96,540

(-96.54%)

Returns from Scinai Immunotherapeutics Stock

-₹96,770 (-96.77%)

Dollar Impact

₹230 (+0.23%)

Analyst Recommendation on Scinai Immunotherapeutics Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Scinai Immunotherapeutics. Average target price of $700

Scinai Immunotherapeutics Share Price Target

Get share price movements and forecasts by analysts on Scinai Immunotherapeutics.

What analysts predicted

99.93%UPSIDE

Target Price

$700

Current Price

$0.4716

Analyzed by

7 Analysts

Target

$700.00

Scinai Immunotherapeutics target price $700, a slight upside of 99.93% compared to current price of $0.4716. According to 7 analysts rating.

Indian Investors' Interest in Scinai Immunotherapeutics Stock

Search interest for Scinai Immunotherapeutics Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-35% versus previous 30 day period

Scinai Immunotherapeutics Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
0
0
0
0
0
0
0
Gross Profit
-
0
-
0
0
0
0
0
-1
-1
Operating Income
-2
-1
-1
3
-2
-1
-1
-1
-2
-2
EBITDA
-1
-1
-1
-1
12
-1
-1
-1
-2
-1
Interest Expense
-
0
0
0
1
-
0
-
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
3
-2
-2
-2
10
-1
-2
-2
3
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
3
-2
-2
-2
10
-1
-2
-2
3
-2
Net Profit Margin
0.00%
0.00%
0.00%
-57.75%
-148.21%
38.91%
-164.29%
-256.88%
-228.63%
-272.17%

Scinai Immunotherapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Mar 2019
Mar 2020
Mar 2021
Dec 2021
Mar 2023
Dec 2023
Mar 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
0
1
Gross Profit
-
-
-
0
0
-
-
0
-2
Operating Income
-6
-20
-22
-19
-10
-11
-9
-8
-7
EBITDA
-6
-20
-22
-19
-10
-5
-2
-6
-6
Interest Expense
0
3
4
0
3
-
3
1
0
Depreciation
0
0
0
0
0
0
0
1
1
Income Before Tax
-9
-23
-31
-1
-12
-5
-6
4
-8
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-9
-23
-31
-1
-12
-5
-6
4
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-88.15%
-202.29%

Scinai Immunotherapeutics Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
3
-2
-2
-2
10
-1
-2
-2
3
-2
Operating Cash Flow
-2
-1
-1
-1
-2
-1
-1
-1
-1
-2
Investing Cash Flow
0
0
0
0
0
0
0
0
2
0
Financing Cash Flow
1
-
1
0
0
0
1
2
0
2
Change in Cash
-1
-1
0
-1
-2
0
0
-
1
0

Scinai Immunotherapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Mar 2019
Mar 2020
Mar 2021
Dec 2021
Mar 2023
Dec 2023
Mar 2025
Mar 2026
Net Income
-9
-23
-31
-1
-8
-5
-6
4
-8
Operating Cash Flow
-2
-15
-22
-21
-7
-7
-9
-6
-6
Investing Cash Flow
1
-6
-2
-1
0
0
0
0
0
Financing Cash Flow
17
22
24
3
21
6
1
3
5
Change in Cash
16
0
0
-18
14
-3
-9
-2
0

Global Institutional Holdings in Scinai Immunotherapeutics

Check out the Institutions with significant holdings in Scinai Immunotherapeutics.

Funds
Holdings
CapTrust Financial Advisors
0.09%
Virtu Financial LLC
0.00%
TWO SIGMA SECURITIES, LLC
0.00%
UBS Group AG
0.03%
Citadel Advisors Llc
0.00%

Scinai Immunotherapeutics News & Key Events

  • img

    Today's Timeline - 13 October

    Tue, 05:37 PM

    -

    Scinai Immunotherapeutics secures $5.1 million CDMO deal, tripling committed orders to $7.6 million.

Insights on Scinai Immunotherapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 193.3% return, outperforming this stock by 292.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 816.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SCNI stock has moved down by -8.1%

About Scinai Immunotherapeutics

Scinai Immunotherapeutics Ltd. operates as an emerging biopharmaceutical company, dedicated to the research, production, and market introduction of medical solutions. Based in Israel, its primary objective is the prevention and treatment of a range of infectious, autoimmune, and other health conditions. The company maintains a significant licensing and collaboration agreement with the Max Planck Society and the University Medical Center Göttingen. This partnership is focused on advancing and commercializing a nanosized antibody (NanoAb) specifically for COVID-19, in addition to pursuing NanoAb applications for various other disease indications. Established in 2003, the company was formerly known as BiondVax Pharmaceuticals Ltd. before rebranding to Scinai Immunotherapeutics Ltd. in September 2023. Its corporate headquarters are situated in Jerusalem, Israel.
OrganisationScinai Immunotherapeutics
HeadquartersJerusalem BioPark Building, Jerusalem, JM, 9112001, IL
IndustryBiotechnology
CEOAmir Reichman

Key Management of Scinai Immunotherapeutics

Name

Title

Gal Ron

Head of HR

Merav Kamensky

Head of Quality Control & GMP Analytics

Dr. Naama Adi Hen

Head of Quality Asurance

Mr. Eran Kuratz

Head of Supply Chain & Business Process Administration

Mr. Amir Reichman M.B.A., M.Sc.

CEO & Director

Mr. Elad Mark B.Sc., Eng., M.B.A.

Chief Operating Officer

FAQs

What is Scinai Immunotherapeutics share price today?

Scinai Immunotherapeutics share price today is $0.47 as on at the close of the market. Scinai Immunotherapeutics share today touched a day high of $0.52 and a low of $0.47.

What is the 52 week high and 52 week low for Scinai Immunotherapeutics share?

Scinai Immunotherapeutics share touched a 52 week high of $15.50 on and a 52 week low of $0.50 on . Scinai Immunotherapeutics stock price today i.e. is closed at $0.47,which is 96.96% down from its 52 week high and -6.24% up from its 52 week low.

What is Scinai Immunotherapeutics's market capitalisation today?

Scinai Immunotherapeutics market capitalisation is $0.00T as on .

How to invest in Scinai Immunotherapeutics Stock (SCNI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Scinai Immunotherapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Scinai Immunotherapeutics Stock (SCNI) from India?

Indian investors can start investing in Scinai Immunotherapeutics (SCNI) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Scinai Immunotherapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Scinai Immunotherapeutics share’s latest price of $0.47 as on October 31, 2026 at 8:45 am IST, you will get 21.2044 shares of Scinai Immunotherapeutics. Learn more about fractional shares .